Peter Wolfe - May 24, 2023 Form 4 Insider Report for ZyVersa Therapeutics, Inc. (ZVSA)

Role
Chief Financial Officer
Signature
/s/ Peter Wolfe
Stock symbol
ZVSA
Transactions as of
May 24, 2023
Transactions value $
$0
Form type
4
Date filed
7/18/2024, 09:35 PM
Previous filing
Dec 20, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZVSA Stock Options Award $0 +715 $0.00 715 May 24, 2023 Common Stock 715 $152.46 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option disclosed on this Form 4 was not previously reported due to an administrative oversight.
F2 Share and dollar amounts give effect to the issuer's 1-for-35 reverse stock split effectuated on December 4, 2023, and 1-for-10 reverse stock split effectuated on April 25, 2024.
F3 The option vests annually in three equal installments commencing on May 24, 2024.